606970-32-5

Upstream product

• 141-53-7 sodium formate 
• 606970-26-7 Acetic acid (2R,3R,4R,5S,6R)-5-acetoxy-6-allyl-4-benzyloxy-2-benzyloxymethyl-piperidin-3-yl ester 
• 606970-29-0 Acetic acid (2R,3R,4R,5S,6R)-5-acetoxy-6-allyl-4-benzyloxy-2-benzyloxymethyl-1-naphthalen-2-ylmethyl-piperidin-3-yl ester 
• 606970-27-8 [(R)-1-((3aS,5S,6R,6aS)-6-Benzyloxy-3a-benzyloxymethyl-2,2-dimethyl-tetrahydro-furo[2,3-d][1,3]dioxol-5-yl)-but-3-enyl]-naphthalen-2-ylmethyl-amine 
• 664366-28-3 (2R,3S,4R,5R,6R)-2-Allyl-4-benzyloxy-6-benzyloxymethyl-1-naphthalen-2-ylmethyl-piperidine-3,5-diol 
• 664366-33-0 [1-((3aS,5S,6R,6aS)-6-Benzyloxy-3a-benzyloxymethyl-2,2-dimethyl-tetrahydro-furo[2,3-d][1,3]dioxol-5-yl)-meth-(E)-ylidene]-naphthalen-2-ylmethyl-amine 
• 302788-33-6 3,6-di-O-benzyl-4,5-O-isopropylidene-D-xylo-aldehydo-hexos-5-ulo-2,5-furanose 

Relevant academic research and scientific papers

General access to iminosugar C-glycoside building blocks by means of cross-metathesis: A gateway to glycoconjugate mimetics

Cross-metathesis reactions of α-1-C-allyl-1-deoxynojirimycin derivatives 7a,b and various functionalized alkenes mediated by Grubbs's catalyst 3 are reported. The reactions showed reasonable to very good yields and excellent E/Z selectivity. This methodol